Chad M. Robins
Known title: CEO and ChairmanCIK: 0001780649
Associated companies
Transaction History
| ADPT | ▼ Sell | Open Market | 204 | $5K | 8/18/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 278,676 | $1.8M | 8/18/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 278,472 | $6.8M | 8/18/2026 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 321,324 | $2.1M | 8/17/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 318,799 | $8.0M | 8/17/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 2,525 | $65K | 8/17/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 37,263 | $566K | 4/8/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 83,332 | $1.2M | 4/6/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 140,567 | $1.9M | 3/11/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 329,600 | $4.3M | 3/11/2026 | View on chart |
| ADPT | ▲ Buy | Grant | 709,220 | $0 | 3/6/2026 | View on chart |
| ADPT | ▲ Buy | Grant | 127,813 | $0 | 3/4/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 50,703 | $785K | 3/3/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 2,380 | $38K | 3/3/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 289,024 | $4.6M | 3/2/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 182,891 | $2.9M | 2/27/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 124,998 | $2.3M | 2/2/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 124,998 | $1.9M | 1/5/2026 | View on chart |
| ADPT | ▼ Sell | Open Market | 124,998 | $2.4M | 12/1/2025 | View on chart |
| ADPT | ▼ Sell | Open Market | 35,736 | $703K | 11/26/2025 | View on chart |
| ADPT | ▼ Sell | Open Market | 1,867 | $28K | 11/12/2025 | View on chart |
| ADPT | ▼ Sell | Open Market | 1,237 | $18K | 11/11/2025 | View on chart |
| ADPT | ▼ Sell | Open Market | 86,161 | $1.3M | 11/10/2025 | View on chart |
| ADPT | ▼ Sell | Open Market | 102,218 | $781K | 3/6/2025 | View on chart |
| ADPT | ▲ Buy | Grant | 247,117 | $0 | 3/5/2025 | View on chart |
| ADPT | ▼ Sell | Open Market | 81,206 | $567K | 3/5/2025 | View on chart |
| ADPT | ▼ Sell | Open Market | 36,145 | $253K | 3/5/2025 | View on chart |
| ADPT | ▲ Buy | Grant | 355,000 | $0 | 3/4/2025 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 99,107 | $626K | 2/20/2025 | View on chart |
| ADPT | ▼ Sell | Open Market | 99,107 | $836K | 2/20/2025 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 186,080 | $1.2M | 2/19/2025 | View on chart |
| ADPT | ▼ Sell | Open Market | 186,080 | $1.6M | 2/19/2025 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 211,160 | $1.3M | 2/18/2025 | View on chart |
| ADPT | ▼ Sell | Open Market | 211,160 | $1.8M | 2/18/2025 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 158,921 | $1.0M | 2/14/2025 | View on chart |
| ADPT | ▼ Sell | Open Market | 158,921 | $1.3M | 2/14/2025 | View on chart |
| ADPT | ▼ Sell | Open Market | 100,287 | $846K | 2/13/2025 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 100,287 | $634K | 2/13/2025 | View on chart |
| ADPT | ▼ Sell | Open Market | 42,794 | $147K | 3/5/2024 | View on chart |
| ADPT | ▼ Sell | Open Market | 5,879 | $20K | 3/5/2024 | View on chart |
| ADPT | ▲ Buy | Grant | 354,610 | $0 | 3/4/2024 | View on chart |
| ADPT | ▲ Buy | Grant | 354,610 | $0 | 3/6/2023 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,815 | $94K | 3/9/2022 | View on chart |
| ADPT | ▼ Sell | Open Market | 14,815 | $185K | 3/9/2022 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,815 | $94K | 3/8/2022 | View on chart |
| ADPT | ▼ Sell | Open Market | 14,815 | $169K | 3/8/2022 | View on chart |
| ADPT | ▼ Sell | Open Market | 4,424 | $53K | 3/7/2022 | View on chart |
| ADPT | ▲ Buy | Option Exercise | 14,815 | $94K | 3/7/2022 | View on chart |
| ADPT | ▼ Sell | Open Market | 500 | $6K | 3/7/2022 | View on chart |
| ADPT | ▼ Sell | Open Market | 14,315 | $165K | 3/7/2022 | View on chart |
| ADPT | ▲ Buy | Grant | 247,117 | $0 | 3/4/2022 | View on chart |
| ADPT | ▼ Sell | Open Market | 4,902 | $188K | 9/10/2021 | View on chart |
| ADPT | ▼ Sell | Open Market | 98 | $4K | 9/10/2021 | View on chart |
| ADPT | ▼ Sell | Open Market | 24,753 | $951K | 9/9/2021 | View on chart |
| ADPT | ▼ Sell | Open Market | 11,742 | $450K | 9/8/2021 | View on chart |
| ADPT | ▼ Sell | Open Market | 2,004 | $78K | 9/8/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Adaptive Biotechnologies Fair Value Lifted on MRD Optimism
Adaptive Biotechnologies saw a modest increase in its fair value estimate driven by optimism regarding minimal residual disease (MRD) data. This development provides a fundamental reason for potential valuation adjustments, distinct from the technical indicators currently showing a negative divergence. The stock remains within its 52-week range, with analysts maintaining a higher average target price than the current market levels.
Adaptive Biotechnologies Fair Value Lifted on MRD Optimism. Adaptive Biotechnologies saw a modest increase in its fair value estimate driven by optimism regarding minimal residual disease (MRD) data. This development provides a fundamental reason for potential valuation adjustments, distinct from the technical indicators currently showing a negative divergence. The stock remains within its 52-week range, with analysts maintaining a higher average target price than the current market levels.